Mycoprotein-Based Chemical Binders Market (2026 - 2036)

Mycoprotein-Based Chemical Binders Market Forecast and Outlook 2026 to 2036

In 2025, the mycoprotein-based chemical binders market was valued at USD 24 million. Based on Fact.MR analysis, demand for mycoprotein-based chemical binders is estimated to reach USD 28 million in 2026 and USD 145 million by 2036. Fact.MR projects a CAGR of 17.9% during the forecast period. Growth reflects early-stage commercialization of fungal and mycelium-derived binders in applications where bio-based adhesion performance can replace synthetic resins without process redesign.

The market adds approximately USD 121 million in absolute value over the forecast window, signalling scale-up driven expansion rather than incremental replacement. Early-period growth is led by wood bonding applications in interior construction and engineered panels, where fungal protein binders meet strength and curing requirements. Mid-period momentum aligns with insulation and packaging use cases, supported by lightweight composite integration. In later years, value realization is influenced by automotive interior and non-structural components, where binder performance validation enables broader qualification.

The United Kingdom leads growth at 16.2% CAGR, supported by pilot-to-commercial transition of mycelium materials and public procurement interest. The United States follows at 14.8%, driven by construction material innovation and venture-backed scaling. The Netherlands records 13.5%, reflecting advanced bio-material research and circular building initiatives, while Germany posts 12.2%, constrained by stringent material certification but supported by automotive and construction testing pipelines.

Mycoprotein Based Chemical Binders Market Definition

The mycoprotein based chemical binders market covers binding agents produced from fungal biomass that are used to hold materials together in industrial and material processing applications. Mycoprotein is derived from controlled fermentation of filamentous fungi and processed to obtain protein rich structures with adhesive and binding properties. These binders are used in applications where biological origin materials are required, such as molded products, composite materials, and specialty industrial formulations. Oversight of microbial fermentation processes and chemical substance safety is governed by frameworks administered by the US Food and Drug Administration and chemical control programs managed by the US Environmental Protection. [1]

Mycoprotein Based Chemical Binders Market Inclusions

The report covers global and regional market size estimates in volume and value terms with a forecast period from 2026 to 2036. Segmentation includes binder form, dry and liquid, production route through fungal fermentation, application across composite materials, molded products, and specialty industrial uses, and end use industries including construction materials, packaging, and industrial manufacturing. The scope also includes regional demand patterns, pricing benchmarks, and international trade flows for bio based binding agents.

Mycoprotein Based Chemical Binders Market Exclusions

The scope excludes food grade mycoprotein products intended for human consumption and animal feed applications. Conventional synthetic binders such as urea formaldehyde, phenolic resins, and epoxy systems are not included. Finished consumer goods, engineered composites sold as end products, and downstream assemblies are excluded. Raw fermentation feedstocks, enzymes, processing equipment, laboratory scale research materials, pilot scale production without commercial output, and contract manufacturing services are also outside the scope.

Mycoprotein Based Chemical Binders Market Research Methodology

• Primary Research: Primary research involved interviews with fermentation technology developers, binder manufacturers, materials engineers, and procurement managers in industrial materials supply chains.
• Desk Research: Desk research used regulatory guidance on microbial products and chemical substances issued by the US Food and Drug Administration and the US Environmental Protection Agency, along with company annual reports and chemical safety filings.
• Market Sizing and Forecasting: Market sizing applied a hybrid top down and bottom up model using reported fermentation capacity, biomass yield assumptions, binder formulation rates, and downstream material consumption indicators.
• Data Validation and Update Cycle: Outputs were cross checked against regulatory registrations, trade statistics, company disclosures, and publicly available chemical production data, with updates applied when verified public sources issue revisions.

Summary of mycoprotein-based chemical binders market

• Market definition

  • The mycoprotein-based chemical binders market covers binding agents derived from fungal biomass and mycelium that are used to bond or stabilize materials in construction, packaging, insulation, and selected industrial composite applications.

• Demand drivers

  • Wood panel and interior construction manufacturers are evaluating fungal protein binders as substitutes for formaldehyde-based resins to meet composite wood emission limits enforced under indoor air quality regulations.
  • Packaging and insulation producers are adopting mycelium and fungal protein binders where lightweight composites and fiber-based materials require compatible, low-temperature curing binder systems.
  • Expansion of microbial fermentation and bio-manufacturing capacity under government-supported bioeconomy programs is improving supply consistency and scale economics, as outlined.

• Key segments analyzed

  • Material type: Fungal protein-based binders lead with about 62% share due to controlled fermentation enabling uniform binding performance and repeatable formulation quality.
  • Application: Wood bonding accounts for roughly 45% share, reflecting demand from engineered panels, interior construction materials, and furniture components.
  • Geography: The United Kingdom, United States, Netherlands, and Germany show higher growth linked to pilot-to-commercial transitions, construction material testing pipelines, and biobased materials research ecosystems.

• Analyst opinion at Fact.MR

  • Shambhu Nath Jha, Principal Consultant at Fact.MR, opines, ‘CXOs will find this report useful for understanding how performance validation, manufacturing line compatibility, and certification pathways are governing scale-up of mycoprotein-based chemical binders.’

• Strategic Implications / Executive Takeaways

  • Prioritize binder formulations that match press temperatures, cure times, and strength profiles of existing wood and composite production lines.
  • Focus early commercialization on non-structural construction and interior applications with shorter certification timelines.
  • Build partnerships with fermentation technology providers to secure consistent fungal biomass supply at commercial scale.

• Methodology

  • Market sizing based on fermentation capacity, biomass yield assumptions, and binder usage rates by application.
  • Validation through regulatory references, producer disclosures, and trade data.
  • Forecasts developed using reproducible top-down and bottom-up models aligned with verified industrial benchmarks.

Mycoprotein-Based Chemical Binders Market Drivers, Restraints, And Opportunities

Fact.MR analysis indicates that the mycoprotein-based chemical binders market exists as a bio-derived binder segment within food, feed, and industrial formulation value chains where adhesion, texture, and functional performance are required. As per Fact.MR assessment, mycoprotein-derived binders use protein fractions extracted from filamentous fungal biomass to replace or augment conventional binders such as gluten, starch, or synthetic polymers; commercial adoption is influenced by regulatory frameworks governing food ingredient safety and functional additives, such as inclusion on the U.S. Food and Drug Administration (FDA) food additives list, which defines acceptable uses and labelling for novel binder ingredients in food products [4]. Fact.MR analysts observe that the current market scale reflects selective uptake in segments where protein-based functionality and clean-label positioning align with buyer requirements, rather than broad substitution of established binder chemistries.

Fact.MR is of the opinion that the market is undergoing transitionary dynamics as sustainability criteria and functional performance expectations evolve. Based on Fact.MR assessment, conventional synthetic binder systems and starch-based binders retain large volume use because of cost advantages and historical specification norms, but growth in mycoprotein-based binders occurs where formulation performance, moisture retention, and texture enhancement matter to product developers. Mycoprotein-based chemical binders generally carry higher per-unit pricing because of cultivation, extraction, and processing complexity, which can support realised market value growth even where shipment volumes grow at a measured pace. Fact.MR analysis suggests that this balance between niche adoption and premium pricing defines near-term market behaviour in segments where consumer preference and functional criteria drive specification.

• Regulated food additive criteria: Fact.MR analysts note that regulatory frameworks such as the U.S. Food and Drug Administration (FDA) food additives list govern acceptable uses, safety requirements, and labelling expectations for mycoprotein-derived chemical binders in food applications.
• Functional binder adoption trends: Based on Fact.MR assessment, increasing interest in protein-based binder alternatives supports growth in food and feed formulations where texture, moisture management, and clean-label positioning are specified.
• EU novel food and ingredient frameworks: Fact.MR opines that compliance with European Union novel food and ingredient evaluation requirements influences importer and producer planning for mycoprotein-based binder products in European markets.

Competitive Landscape of Mycoprotein-Based Chemical Binders Market

As per Fact.MR analysis, the 2026 mycoprotein-based chemical binders market is defined by validated material performance, feedstock scalability, and regulatory compliance, which determine competitive advantage. Ecovative Design and Mogu S.r.l. lead with proprietary fungal protein formulations and documented binding strength, which strengthens adoption in construction, packaging, and insulation applications. Bolt Threads and Grown.bio focus on scalable mycelium cultivation with validated reproducibility and consistency, which improves process reliability and supports multi-region compliance. Biohm Ltd. emphasizes hybrid binder systems and verified mechanical performance, which increases adoption in modular construction and sustainable product applications. Other smaller players provide specialty formulations with tested biodegradability and material properties, which address niche industrial and consumer applications. Across the market, validated functional performance, scalable production, and adherence to regulatory and sustainability standards create enduring competitive moats, reducing reliance on pricing or isolated innovation claims while ensuring long-term industrial and commercial adoption.

Recent Industry Developments

• Quorn Foods (Marlow Foods): Transition to Vegan Binders: In its 2025/2026 Sustainability and Product Roadmap, Quorn announced a major shift in its manufacturing process to eliminate egg-white binders. By leveraging high-pressure homogenization and specialized freezing techniques, Quorn has successfully enabled mycoprotein’s own chitin-glucan fibers to act as a self-binding matrix, creating "clean-label" vegan products without external chemical binders. [5]
• ENOUGH (Abunda): B2B Scale-Up with Cargill: ENOUGH (formerly 3FBio) has fully commissioned its flagship facility in the Netherlands, integrated with a Cargill refinery. As of early 2026, the company is supplying ABUNDA® mycoprotein as a functional binder to global food manufacturers. This ingredient is being marketed specifically for its ability to provide structural integrity and "whole-muscle" texture in hybrid and plant-based foods. [6]

Scope of the Report

Bibliography

• [1] U.S. Food and Drug Administration. (2024). Food additive petitions and ingredient approval framework. U.S. Department of Health and Human Services; U.S. Environmental Protection Agency. (2024). Chemical research and microbial product oversight. U.S. Environmental Protection Agency.
• [2] U.S. Department of Energy. (2024). Bioenergy Technologies Office: Industrial biotechnology and bio-based materials. Office of Energy Efficiency and Renewable Energy, U.S. Department of Energy.
• [3] U.S. Environmental Protection Agency. (2024). Formaldehyde emission standards for composite wood products. U.S. Environmental Protection Agency.
• [4] U.S. Food and Drug Administration. (2024). Food additives and ingredients: Safety, use, and labelling requirements. U.S. Department of Health and Human Services.
• [5] Marlow Foods Ltd. (Quorn Foods). (2025). Sustainability and product roadmap: Mycoprotein processing and binding innovation. Quorn Foods.
• [6] ENOUGH B.V. (2026). ABUNDA® mycoprotein production scale-up and Cargill partnership announcement. ENOUGH Official Corporate Communications.